This report examines the UK’s evolving life sciences environment and discusses opportunities to further enhance the UK as a life science hub for the benefit of patients, the NHS, and the wider economy, including how the innovative medicines pathway could be strengthened and made fit for the future.
Our Research
Our Bridging the Gap work looks at global trends in the development of medicines and access processes. The series of reports set out recommended policy solutions that aim to help create a more accessible pathway to ensure patients can get access to new innovative treatments quicker.
Taking Stock of the UK life sciences environment
Exploring the evolution of medicine regulatory policy in the UK
Our research identifies trends in the global medicines regulatory environment. In this report we explore policy solutions that could enable the creation of innovative approaches to medicines regulation in the UK which supports early patient access to new, innovative treatments.
Turning innovation into patient care
Drawing on research commissioned by AbbVie, which examined different international technology appraisal systems, this report considers if international approaches could support the acceleration of new and innovative medicines to patients in Scotland.
June 2024
UK-ABBV-240158